These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28395400)

  • 41. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C; Dehesa L; Vega A; Kerdel F
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis and latent tuberculosis infection among healthcare workers in Kisumu, Kenya.
    Agaya J; Nnadi CD; Odhiambo J; Obonyo C; Obiero V; Lipke V; Okeyo E; Cain K; Oeltmann JE
    Trop Med Int Health; 2015 Dec; 20(12):1797-804. PubMed ID: 26376085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings.
    Lin AW; Lau SK; Woo PC
    Expert Rev Anti Infect Ther; 2016; 14(5):489-500. PubMed ID: 26999724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reactivation tuberculosis: role of surveillance.
    DiNardo AR; Guy E
    Expert Rev Anti Infect Ther; 2016; 14(5):501-9. PubMed ID: 27042967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tuberculosis screening in a dialysis unit: detecting latent tuberculosis infection is only half the problem.
    Brij SO; Beck SC; Kleemann F; Jack AL; Wilkinson C; Enoch DA
    J Hosp Infect; 2014 Aug; 87(4):241-4. PubMed ID: 25027226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Latent tuberculosis infection as a target for tuberculosis control.
    van Leth F; van Crevel R; Brouwer M
    Future Microbiol; 2015; 10(6):905-8. PubMed ID: 26059614
    [No Abstract]   [Full Text] [Related]  

  • 49. [Accessibility and compliance of Ethiopian immigrants to latent tuberculosis infection treatment].
    Bishara H; Ore L; Bshara H; Vinitsky O; Armaly N; Weiler-Ravell D
    Harefuah; 2014 Jan; 153(1):8-11, 66. PubMed ID: 24605398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting.
    Saidenberg-Kermanac'h N; Semerano L; Naccache JM; Brauner M; Falgarone G; Dumont-Fischer D; Guillot X; Valeyre D; Boissier MC
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies.
    Druszczyńska M; Kowalewicz-Kulbat M; Fol M; Włodarczyk M; Rudnicka W
    Pol J Microbiol; 2012; 61(1):3-10. PubMed ID: 22708341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
    Brassard P; Steensma C; Cadieux L; Lands LC
    Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-α inhibitor.
    Byun JM; Lee CK; Rhee SY; Kim HJ; Im JP; Park DI; Eun CS; Jung SA; Shin JE; Lee KM; Cheon JH
    Scand J Gastroenterol; 2015 Mar; 50(3):312-20. PubMed ID: 25581784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.
    Sánchez-Moya AI; García-Doval I; Carretero G; Sánchez-Carazo J; Ferrandiz C; Herrera Ceballos E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez-García F; De la Cueva Dobao P; Carrascosa JM; Vanaclocha F; Belinchón I; Peral F; Dauden E;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1366-74. PubMed ID: 23134268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    McCarthy KM; Scott LE; Gous N; Tellie M; Venter WD; Stevens WS; Van Rie A
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):647-53. PubMed ID: 25946353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further evidence supporting programmatic screening for, and treatment of latent TB Infection (LTBI) in new entrants to the UK from high TB prevalence countries.
    Ormerod LP
    Thorax; 2013 Mar; 68(3):201. PubMed ID: 22993166
    [No Abstract]   [Full Text] [Related]  

  • 60. Reflecting on the updates to the World Health Organisation 2019 Tuberculosis Infection Control Guidelines through the lens of a low-income/high TB burden country.
    Islam MS; Chughtai AA; Seale H
    J Infect Public Health; 2020 Aug; 13(8):1057-1060. PubMed ID: 32241724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.